Psoriasis Clinical Trial

Plaque Psoriasis Study in Pediatric Subjects

Summary

The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female 2 to 12 years of age
Clinical diagnosis of stable mild to moderate plaque psoriasis

Exclusion Criteria:

Other forms of psoriasis
Hypercalcemia
Past history of kidney stones
Vitamin D deficiency
Other concomitant dermatological disease

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

19

Study ID:

NCT02186665

Recruitment Status:

Completed

Sponsor:

Galderma R&D

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 34 Locations for this study

See Locations Near You

David Stoll, MD
Beverly Hills California, 90212, United States
Center for Dermatology and Laser Surgery
Sacramento California, 95819, United States
Dermatology Specialists Research
Louisville Kentucky, 40202, United States
University of Mississippi Medical Center
Jackson Mississippi, 39216, United States
Montefiore Medical Center
Bronx New York, 10467, United States
RCMC Center for Dermatology at Linden Oaks
Rochester New York, 14625, United States
Clinical Partners, LLC
Johnston Rhode Island, 02919, United States
Dermatology and Laser Center of Charleston
Charleston South Carolina, 29414, United States
DermResearch
Austin Texas, 78759, United States
The University of Texas Health Science Center at Houston
Houston Texas, 77030, United States
Clinical Trials of Texas
San Antonio Texas, 78229, United States
Jordan Valley Dermatology
West Jordan Utah, 84088, United States
UCL Saint Luc
Brussel , 1200, Belgium
UZ Ghent
Ghent , 9000, Belgium
CHU de Liège
Liege , 4000, Belgium
Winnipeg Clinic, Dermatology Research
Winnipeg Manitoba, r3con, Canada
Universitätsklinikum Erlangen, Hautklinik
Erlangen , 91054, Germany
Praxis Dr.Beate Schwarz
Langenau , 89129, Germany
Universitäts-Hautklinik Mainz, Johannes Gutenberg-Universität Mainz
Mainz , 55131, Germany
Technical University Munich
Munchen , 80802, Germany
University of Tübingen
Tubingen , 72076, Germany
Heim Pál Gyermekkórház; Bőrgyógyászati Osztály
Budapest , 1089, Hungary
Pécsi Tudományegyetem; Bőr-, Nemikórtani és Onkodermatológiai Klinika
Pecs , 7632, Hungary
Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ; Bőrgyógyászati és Allergológiai Klinika
Szeged , 6720, Hungary
PO G. Rodolico, AOU Policlinico Vittorio Emanuele
Catania , 95123, Italy
Padova University Hospital
Padova , 35128, Italy
University of Parma
Parma , 43126, Italy
Policlinico Tor Vergata
Rome , 00133, Italy
Hospital Universitari Germans Trias i Pujol
Badalona-Barcelona , 8916, Spain
Hospital Sant Joan de Deu
Esplugues de Llobregat , 8950, Spain
Hospital General Universitario Gregorio Marañón
Madrid , 28007, Spain
Hospital Universitario Infanta Leonor
Madrid , 28031, Spain
Hospital Universitario La Paz
Madrid , 28046, Spain
Hospital Universitario Infanta Sofía
San Sebastian de Los Reyes , 28702, Spain

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

19

Study ID:

NCT02186665

Recruitment Status:

Completed

Sponsor:


Galderma R&D

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider